1. A3.12 Intrarenal Foxp3+ Regulatory T Cells Expansion and Decreased Number of Infiltrating CD4+ T Cells in Murine Lupus by IL-2 Therapy. (25th February 2013) Authors: Rose, A; Humrich, JY; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 1(2013) Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A7.06 Low-dose IL-2 therapy in refractory sle: Insights from a phase I/IIA clinical trial. (24th February 2016) Authors: Humrich, JY; von Spee-Mayer, C; Siegert, E; Bertolo, M; Abdirama, D; Rose, A; Enghard, P; Radbruch, A; Burmester, GR; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A9.14 Regulatory T Cell Abnormalities in Patients with SLE Suggest an IL-2-Based Immunotherapy. (25th February 2013) Authors: Spee, C von; Wassermann, N; Humrich, JY; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 1(2013) Page Start: A69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of choroidal substructure perfusion in patients affected by systemic sclerosis: an optical coherence tomography angiography study. (3rd March 2020) Authors: Ranjbar, M; Rothe, M; Klapa, S; Lange, T; Prasuhn, M; Grisanti, S; Riemekasten, G; Humrich, JY Journal: Scandinavian journal of rheumatology Issue: Volume 49:Number 2(2020) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P134/O32 Selective expansion of a thymic-derived and functionally competent regulatory T cell population by low-dose IL-2 therapy in patients with refractory SLE. (March 2019) Authors: Humrich, JY; von Spee-Mayer, C; Siegert, E; Bertolo, M; Rose, A; Abdirama, D; Enghard, P; Stuhlmüller, B; Hiepe, F; Alexander, T; Feist, E; Radbruch, A; Burmester, G-R; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PS5:101 Nuclear antigen-reactive cd4+ t cells are expanded in active sle, correlate with disease activity, invade target organs such as the kidneys, and outnumber their regulatory counterparts. (21st March 2018) Authors: Abdirama, D; Tesch, S; Griessbach, A-S; Scheffold, A; Radbruch, A; Stervbo, U; Babel, N; Burmester, G-R; Humrich, JY; Riemekasten, G; Enghard, P Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SP0134 INTERLEUKIN-2 therapy in sle. (15th June 2017) Authors: Humrich, JY Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SP0183 Failure of treg control to understand autoimmunity. (15th June 2017) Authors: Humrich, JY Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗